[7] Wang Z*, Zhao Y*, Wang Q*, Xing Y*, Feng L, Kong J, Peng C, Zhang L#, Yang H#, Lu M#. Signal Transduction and Targeted Therapy 2021;6(1):214. 
https://pubmed.ncbi.nlm.nih.gov/34075025/ 

[8] Lu M, Zak J, Chen S, Sanchez-Pulido L, Severson DT, Endicott J, Ponting CP, Schofield CJ, Lu X#: A code for RanGDP binding in ankyrin repeats defines a nuclear import pathway. Cell 2014, 157:1130-45.
https://pubmed.ncbi.nlm.nih.gov/24855949/
[9] Lu M, Breyssens H, Salter V, Zhong S, Hu Y, Baer C, Ratnayaka I, Sullivan A, Brown NR, Endicott J, Knapp S, Kessler BM, Middleton MR, Siebold C, Jones EY, Sviderskaya EV, Cebon J, John T, Caballero OL, Goding CR, Lu X#: Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP. Cancer Cell 2013, 23:618-33.
https://pubmed.ncbi.nlm.nih.gov/23623661/

[10] Lu M, Muers MR, Lu X#: Introducing STRaNDs: shuttling transcriptional regulators that are non-DNA binding. Nature Reviews Molecular Cell Biology 2016, 17:523-32.
https://pubmed.ncbi.nlm.nih.gov/27220640/